Home

Advent Partners GPE VIII Limited Partnership

CIK 1676941 · last filed 2023-07-06

Advent Partners GPE VIII Limited Partnership is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $66.5M of FWRG on Jul 6, 2023. Across all open-market trades the lifetime net is −$1.36B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $386.9M across reported positions. The firm reports its address in Boston, MA. 22 SEC filings were submitted jointly with ADVENT INTERNATIONAL, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$386.92M

Companies

2

Total Filings

5

Lifetime Open-Market Net

-$1.36B

Filer Profile

Reported Address
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSON STREET, SUITE 3300
BOSTON, MA 02199
Phone
(617) 951-9400
State of Incorporation
DE
Related Filers
ADVENT INTERNATIONAL, L.P. — 22 joint filings, latest 2024-11-15
Advent Partners GPE VIII Cayman Limited Partnership — 19 joint filings, latest 2024-11-15
Advent Partners GPE VIII-A Cayman Limited Partnership — 19 joint filings, latest 2024-11-15
AP GPE VIII GP Limited Partnership — 18 joint filings, latest 2024-11-15
Advent Partners GPE VIII-A Limited Partnership — 18 joint filings, latest 2023-07-06
Advent Partners GPE VIII-B Cayman Limited Partnership — 17 joint filings, latest 2023-07-06
Advent International GPE VIII, LLC — 10 joint filings, latest 2024-11-15
Advent International GPE VII-A Limited Partnership — 8 joint filings, latest 2021-06-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FWRG 10%+ Owner 34,089,784 $11.35 $386.92M -$993.58M 3 2023-07-06
Syneos Health, Inc. (SYNH) Delisted 10%+ Owner 6,307,489 $42.98 $271.10M -$363.82M 1 2021-05-18

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-07-06 FWRG Sell (S) −4,050,000 -$66.52M EDGAR
2023-06-15 FWRG Sell (S) −24,000,000 -$394.18M EDGAR
2022-09-21 FWRG Sell (S) −36,000,000 -$532.89M EDGAR
2021-05-18 Syneos Health, Inc. (SYNH) Delisted Sell (S) −4,489,420 -$363.82M EDGAR
2020-04-01 — Buy (P) +287,744,139 $7.80B
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.